Drug Shortage Report for SANDOZ ALFUZOSIN
Report ID | 174953 |
Drug Identification Number | 02304678 |
Brand name | SANDOZ ALFUZOSIN |
Common or Proper name | ALFUZOSIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ALFUZOSIN HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100PRT |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-16 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-18 |
Shortage status | Resolved |
Updated date | 2023-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-01-19 | French | Compare |
v10 | 2023-01-19 | English | Compare |
v9 | 2022-12-28 | French | Compare |
v8 | 2022-12-28 | English | Compare |
v7 | 2022-12-12 | French | Compare |
v6 | 2022-12-12 | English | Compare |
v5 | 2022-11-28 | French | Compare |
v4 | 2022-11-28 | English | Compare |
v3 | 2022-11-17 | English | Compare |
v2 | 2022-11-16 | French | Compare |
v1 | 2022-11-16 | English | Compare |
Showing 1 to 11 of 11